GlassScriptPhysician profile
Cesar G Morales
NPI 1205368586
$757.40
in general payments reported to CMS, 2019-2025
12 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2022: $170 · 2023: $102 · 2024: $172 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $209.84 | 2022-2025 | Freestyle Libre 3 |
| E.R. Squibb & Sons, L.L.C. | $124.03 | 2021 | |
| Asahi Intecc USA, INC. | $92.08 | 2025 | Asahi Interventional Radiology Wires |
| Lilly USA, LLC | $80.18 | 2024-2025 | Mounjaro, Zepbound |
| Amgen INC. | $70.72 | 2023-2024 | Otezla, Repatha |
| Novo Nordisk INC | $44.84 | 2024 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $33.69 | 2023-2024 | Arexvy, Shingrix |
| Sobi, INC | $27.75 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.20 | 2022 | |
| Dexcom, INC. | $22.01 | 2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $14.75 | 2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Pfizer INC. | $14.31 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cesar Morales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.